Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodiesNoriko Makita(The University of Tokyo), Taroh Iiri(St. Marianna University School of Medicine)JCI InsightSeptember 19, 202210.1172/jci.insight.156742Cited by 9SaveCiteExport RISWatch citationsRelated PapersCinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody|JCI Insight|2019|17Molecular analysis and literature-based hypothesis of an immunonegative prostate small cell carcinoma causing ectopic ACTH syndrome|Endocrine Journal|2019|7